Polycaprolactone‐hydroxy apatite composites for tissue engineering applications

Abstract

In this study, scaffolds with polycaprolactone (PCL) and hydroxy apatite (HA) were produced. Their properties are not sufficient to be used alone. Oleic Acid (OA) and glycerol monooleate (GMO) as organic additives were selected for a homogeneous distribution of the ceramic material in the polymer matrix. Biocomposite materials were prepared with solvent casting‐salt leaching technique using dichloromethane as the solvent. Salt was used as the porosifier. Materials were kept in simulated body fluid (SBF) to determine the bioactivity in vitro conditions. FTIR and EDX analyses for chemical characterization, tensile and compressive tests for mechanical properties, SEM analyses for surface properties and BET analyses for pore sizes, total surface areas and total pore volumes of scaffolds were performed. FTIR, EDX, and SEM analyses were repeated after SBF treatment. Pore diameters were highly increased with 3 and 20 wt% HA addition. Small amount of GMO addition is more effective on pore size. Mechanical properties of scaffolds were suitable for soft tissue applications, as smooth muscle cells, skin and cancellous bone. The cytotoxicity and cell proliferation on scaffolds were studied with smooth muscle cells (SMC) and L929 fibroblastic cells in vitro. No cytotoxic effect was observed for the scaffolds in both cell types. J. VINYL ADDIT. TECHNOL., 24:248–261, 2018. © 2016 Society of Plastics Engineers